1. Home
  2. CYTO vs AVGR Comparison

CYTO vs AVGR Comparison

Compare CYTO & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTO
  • AVGR
  • Stock Information
  • Founded
  • CYTO 2003
  • AVGR 2007
  • Country
  • CYTO Bermuda
  • AVGR United States
  • Employees
  • CYTO N/A
  • AVGR N/A
  • Industry
  • CYTO Biotechnology: Pharmaceutical Preparations
  • AVGR Medical/Dental Instruments
  • Sector
  • CYTO Health Care
  • AVGR Health Care
  • Exchange
  • CYTO Nasdaq
  • AVGR Nasdaq
  • Market Cap
  • CYTO 2.0M
  • AVGR 2.0M
  • IPO Year
  • CYTO N/A
  • AVGR 2015
  • Fundamental
  • Price
  • CYTO $0.41
  • AVGR $0.49
  • Analyst Decision
  • CYTO
  • AVGR Strong Buy
  • Analyst Count
  • CYTO 0
  • AVGR 1
  • Target Price
  • CYTO N/A
  • AVGR $5.00
  • AVG Volume (30 Days)
  • CYTO 182.2K
  • AVGR 194.1K
  • Earning Date
  • CYTO 09-24-2024
  • AVGR 11-07-2024
  • Dividend Yield
  • CYTO N/A
  • AVGR N/A
  • EPS Growth
  • CYTO N/A
  • AVGR N/A
  • EPS
  • CYTO N/A
  • AVGR N/A
  • Revenue
  • CYTO N/A
  • AVGR $7,262,000.00
  • Revenue This Year
  • CYTO N/A
  • AVGR N/A
  • Revenue Next Year
  • CYTO N/A
  • AVGR $93.49
  • P/E Ratio
  • CYTO N/A
  • AVGR N/A
  • Revenue Growth
  • CYTO N/A
  • AVGR N/A
  • 52 Week Low
  • CYTO $0.40
  • AVGR $0.39
  • 52 Week High
  • CYTO $3.60
  • AVGR $5.45
  • Technical
  • Relative Strength Index (RSI)
  • CYTO 43.48
  • AVGR 22.72
  • Support Level
  • CYTO $0.40
  • AVGR $0.42
  • Resistance Level
  • CYTO $0.58
  • AVGR $0.73
  • Average True Range (ATR)
  • CYTO 0.06
  • AVGR 0.09
  • MACD
  • CYTO 0.00
  • AVGR -0.03
  • Stochastic Oscillator
  • CYTO 17.14
  • AVGR 21.80

About CYTO Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

About AVGR Avinger Inc.

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Share on Social Networks: